Type 2 cytokines: mechanisms and therapeutic strategies (original) (raw)

• Mosmann, T. R. & Coffman, R. L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7, 145–173 (1989).
  Article CAS PubMed Google Scholar
• Abbas, A. K., Murphy, K. M. & Sher, A. Functional diversity of helper T lymphocytes. Nature 383, 787–793 (1996).
  Article CAS PubMed Google Scholar
• Urban, J. F. Jr et al. IL-13, IL-4Rα, and Stat6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis. Immunity 8, 255–264 (1998).
  Article CAS PubMed Google Scholar
• Chiaramonte, M. G., Donaldson, D. D., Cheever, A. W. & Wynn, T. A. An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J. Clin. Invest. 104, 777–785 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Anthony, R. M. et al. Memory TH2 cells induce alternatively activated macrophages to mediate protection against nematode parasites. Nature Med. 12, 955–960 (2006).
  Article CAS PubMed Google Scholar
• Cliffe, L. J. et al. Accelerated intestinal epithelial cell turnover: a new mechanism of parasite expulsion. Science 308, 1463–1465 (2005).
  Article CAS PubMed Google Scholar
• Hasnain, S. Z. et al. Muc5ac: a critical component mediating the rejection of enteric nematodes. J. Exp. Med. 208, 893–900 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Zhao, A. et al. Dependence of IL-4, IL-13, and nematode-induced alterations in murine small intestinal smooth muscle contractility on Stat6 and enteric nerves. J. Immunol. 171, 948–954 (2003).
  Article CAS PubMed Google Scholar
• Anthony, R. M., Kobayashi, T., Wermeling, F. & Ravetch, J. V. Intravenous gammaglobulin suppresses inflammation through a novel TH2 pathway. Nature 475, 110–113 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Lubberts, E. et al. IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion. J. Clin. Invest. 105, 1697–1710 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Shaw, M. K. et al. Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis. J. Exp. Med. 185, 1711–1714 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• West, G. A., Matsuura, T., Levine, A. D., Klein, J. S. & Fiocchi, C. Interleukin 4 in inflammatory bowel disease and mucosal immune reactivity. Gastroenterology 110, 1683–1695 (1996).
  Article CAS PubMed Google Scholar
• Gause, W. C., Wynn, T. A. & Allen, J. E. Type 2 immunity and wound healing: evolutionary refinement of adaptive immunity by helminths. Nature Rev. Immunol. 13, 607–614 (2013).
  Article CAS Google Scholar
• Wynn, T. A. Fibrotic disease and the TH1/TH2 paradigm. Nature Rev. Immunol. 4, 583–594 (2004).
  Article CAS Google Scholar
• Heredia, J. E. et al. Type 2 innate signals stimulate fibro/adipogenic progenitors to facilitate muscle regeneration. Cell 153, 376–388 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Nguyen, K. D. et al. Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis. Nature 480, 104–108 (2011).
  CAS PubMed PubMed Central Google Scholar
• Wu, D. et al. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 332, 243–247 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Odegaard, J. I. et al. Macrophage-specific PPARγ controls alternative activation and improves insulin resistance. Nature 447, 1116–1120 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Wynn, T. A., Chawla, A. & Pollard, J. W. Macrophage biology in development, homeostasis and disease. Nature 496, 445–455 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Palm, N. W., Rosenstein, R. K. & Medzhitov, R. Allergic host defences. Nature 484, 465–472 (2012).
  Article CAS PubMed Google Scholar
• Erb, K. J., Holloway, J. W., Sobeck, A., Moll, H. & Le Gros, G. Infection of mice with _Mycobacterium bovis_-Bacillus Calmette–Guerin (BCG) suppresses allergen-induced airway eosinophilia. J. Exp. Med. 187, 561–569 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Potian, J. A. et al. Preexisting helminth infection induces inhibition of innate pulmonary anti-tuberculosis defense by engaging the IL-4 receptor pathway. J. Exp. Med. 208, 1863–1874 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Osborne, L. C. et al. Coinfection. Virus-helminth coinfection reveals a microbiota-independent mechanism of immunomodulation. Science 345, 578–582 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Harris, J. et al. T helper 2 cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis. Immunity 27, 505–517 (2007).
  Article CAS PubMed Google Scholar
• Gocheva, V. et al. IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. Genes Dev. 24, 241–255 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Bronte, V. et al. IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice. J. Immunol. 170, 270–278 (2003).
  Article CAS PubMed Google Scholar
• Gallina, G. et al. Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. J. Clin. Invest. 116, 2777–2790 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Gabrilovich, D. I., Ostrand-Rosenberg, S. & Bronte, V. Coordinated regulation of myeloid cells by tumours. Nature Rev. Immunol. 12, 253–268 (2012).
  Article CAS Google Scholar
• Allen, J. E. & Wynn, T. A. Evolution of Th2 immunity: a rapid repair response to tissue destructive pathogens. PLoS Pathog. 7, e1002003 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Wynn, T. A. & Ramalingam, T. R. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nature Med. 18, 1028–1040 (2012).
  Article CAS PubMed Google Scholar
• Allen, J. E. & Maizels, R. M. Diversity and dialogue in immunity to helminths. Nature Rev. Immunol. 11, 375–388 (2011).
  Article CAS Google Scholar
• Pulendran, B. & Artis, D. New paradigms in type 2 immunity. Science 337, 431–435 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Walker, J. A., Barlow, J. L. & McKenzie, A. N. Innate lymphoid cells — how did we miss them? Nature Rev. Immunol. 13, 75–87 (2013).
  Article CAS Google Scholar
• Zhou, L., Chong, M. M. & Littman, D. R. Plasticity of CD4+ T cell lineage differentiation. Immunity 30, 646–655 (2009).
  Article CAS PubMed Google Scholar
• Paul, W. E. & Zhu, J. How are TH2-type immune responses initiated and amplified? Nature Rev. Immunol. 10, 225–235 (2010).
  Article CAS Google Scholar
• Manetti, R. et al. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (TH1)-specific immune responses and inhibits the development of IL-4-producing TH cells. J. Exp. Med. 177, 1199–1204 (1993).
  Article CAS PubMed Google Scholar
• Xu, D. et al. Selective expression and functions of interleukin 18 receptor on T helper (TH) type 1 but not TH2 cells. J. Exp. Med. 188, 1485–1492 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Okamura, H. et al. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 378, 88–91 (1995).
  Article CAS PubMed Google Scholar
• Szabo, S. J., Jacobson, N. G., Dighe, A. S., Gubler, U. & Murphy, K. M. Developmental commitment to the TH2 lineage by extinction of IL-12 signaling. Immunity 2, 665–675 (1995).
  Article CAS PubMed Google Scholar
• Kodama, T. et al. IL-18 deficiency selectively enhances allergen-induced eosinophilia in mice. J. Allergy Clin. Immunol. 105, 45–53 (2000).
  Article CAS PubMed Google Scholar
• Afonso, L. C. et al. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263, 235–237 (1994).
  Article CAS PubMed Google Scholar
• Else, K. J., Finkelman, F. D., Maliszewski, C. R. & Grencis, R. K. Cytokine-mediated regulation of chronic intestinal helminth infection. J. Exp. Med. 179, 347–351 (1994).
  Article CAS PubMed Google Scholar
• Finkelman, F. D. et al. Effects of interleukin 12 on immune responses and host protection in mice infected with intestinal nematode parasites. J. Exp. Med. 179, 1563–1572 (1994).
  Article CAS PubMed Google Scholar
• Maizels, R. M., Pearce, E. J., Artis, D., Yazdanbakhsh, M. & Wynn, T. A. Regulation of pathogenesis and immunity in helminth infections. J. Exp. Med. 206, 2059–2066 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Badalyan, V. et al. TNF-α/IL-17 synergy inhibits IL-13 bioactivity via IL-13Rα2 induction. J. Allergy Clin. Immunol. 134, 975–978. e5 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Kaviratne, M. et al. IL-13 activates a mechanism of tissue fibrosis that is completely TGF-β independent. J. Immunol. 173, 4020–4029 (2004).
  Article CAS PubMed Google Scholar
• Wynn, T. A., Eltoum, I., Oswald, I. P., Cheever, A. W. & Sher, A. Endogenous interleukin 12 (IL-12) regulates granuloma formation induced by eggs of Schistosoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology. J. Exp. Med. 179, 1551–1561 (1994).
  Article CAS PubMed Google Scholar
• Chu, R. S., Targoni, O. S., Krieg, A. M., Lehmann, P. V. & Harding, C. V. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (TH1) immunity. J. Exp. Med. 186, 1623–1631 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Chiaramonte, M. G., Hesse, M., Cheever, A. W. & Wynn, T. A. CpG oligonucleotides can prophylactically immunize against TH2-mediated schistosome egg-induced pathology by an IL-12-independent mechanism. J. Immunol. 164, 973–985 (2000).
  Article CAS PubMed Google Scholar
• Wynn, T. A. et al. An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature 376, 594–596 (1995). This study shows how vaccine-induced immune deviation could be used to prevent the development of type 2 cytokine-dependent disease.
  Article CAS PubMed Google Scholar
• Gavett, S. H. et al. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and TH2 cytokine expression in mice. J. Exp. Med. 182, 1527–1536 (1995).
  Article CAS PubMed Google Scholar
• Hessel, E. M. et al. Immunostimulatory oligonucleotides block allergic airway inflammation by inhibiting TH2 cell activation and IgE-mediated cytokine induction. J. Exp. Med. 202, 1563–1573 (2005). This study identifies the key mechanisms by which immunostimulatory oligonucleotides suppress type 2 immunity.
  Article CAS PubMed PubMed Central Google Scholar
• Campbell, J. D. et al. A limited CpG-containing oligodeoxynucleotide therapy regimen induces sustained suppression of allergic airway inflammation in mice. Thorax 69, 565–573 (2014).
  Article PubMed Google Scholar
• Colegio, O. R. et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature 513, 559–563 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Noy, R. & Pollard, J. W. Tumor-associated macrophages: from mechanisms to therapy. Immunity 41, 49–61 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Weiss, J. M. et al. Macrophage-dependent nitric oxide expression regulates tumor cell detachment and metastasis after IL-2/anti-CD40 immunotherapy. J. Exp. Med. 207, 2455–2467 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Murray, P. J. et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41, 14–20 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Rissoan, M. C. et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science 283, 1183–1186 (1999).
  Article CAS PubMed Google Scholar
• Iwasaki, A. & Kelsall, B. L. Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells. J. Exp. Med. 190, 229–239 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Stumbles, P. A. et al. Resting respiratory tract dendritic cells preferentially stimulate T helper cell type 2 (TH2) responses and require obligatory cytokine signals for induction of TH1 immunity. J. Exp. Med. 188, 2019–2031 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Lambrecht, B. N. & Hammad, H. Biology of lung dendritic cells at the origin of asthma. Immunity 31, 412–424 (2009).
  Article CAS PubMed Google Scholar
• Yoshimoto, T. et al. Basophils contribute to TH2–IgE responses in vivo via IL-4 production and presentation of peptide-MHC class II complexes to CD4+ T cells. Nature Immunol. 10, 706–712 (2009).
  Article CAS Google Scholar
• Sokol, C. L. et al. Basophils function as antigen-presenting cells for an allergen-induced T helper type 2 response. Nature Immunol. 10, 713–720 (2009).
  Article CAS Google Scholar
• Perrigoue, J. G. et al. MHC class II-dependent basophil-CD4+ T cell interactions promote TH2 cytokine-dependent immunity. Nature Immunol. 10, 697–705 (2009).
  Article CAS Google Scholar
• Guilliams, M. et al. Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny. Nature Rev. Immunol. 14, 571–578 (2014).
  Article CAS Google Scholar
• Plantinga, M. et al. Conventional and monocyte-derived CD11b+ dendritic cells initiate and maintain T helper 2 cell-mediated immunity to house dust mite allergen. Immunity 38, 322–335 (2013). These authors identify conventional DCs as the principal subset inducing T H 2 cell-mediated immunity in the lymph nodes, whereas monocyte-derived DCs control allergic inflammation in the lungs.
  Article CAS PubMed Google Scholar
• Borthwick, L.A. et al. Macrophages are critical to the maintenance of IL-13-dependent lung inflammation and fibrosis. Mucosal Immunol. http://dx.doi.org/10.1038/mi.2015.34 (2015).
• Chensue, S. W. et al. Role of monocyte chemoattractant protein-1 (MCP-1) in TH1 (mycobacterial) and TH2 (schistosomal) antigen-induced granuloma formation: relationship to local inflammation, TH cell expression, and IL-12 production. J. Immunol. 157, 4602–4608 (1996).
  CAS PubMed Google Scholar
• Gu, L. et al. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 404, 407–411 (2000).
  Article CAS PubMed Google Scholar
• Jenkins, S. J. et al. Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation. Science 332, 1284–1288 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Jenkins, S. J. et al. IL-4 directly signals tissue-resident macrophages to proliferate beyond homeostatic levels controlled by CSF-1. J. Exp. Med. 210, 2477–2491 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Julia, V. et al. A restricted subset of dendritic cells captures airborne antigens and remains able to activate specific T cells long after antigen exposure. Immunity 16, 271–283 (2002).
  Article CAS PubMed Google Scholar
• Mosser, D. M. & Edwards, J. P. Exploring the full spectrum of macrophage activation. Nature Rev. Immunol. 8, 958–969 (2008).
  Article CAS Google Scholar
• Martinez, F. O. & Gordon, S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 6, 13 (2014).
  Google Scholar
• Gordon, S. Alternative activation of macrophages. Nature Rev. Immunol. 3, 23–35 (2003).
  Article CAS Google Scholar
• Murray, P. J. & Wynn, T. A. Protective and pathogenic functions of macrophage subsets. Nature Rev. Immunol. 11, 723–737 (2011).
  Article CAS Google Scholar
• Murray, P. J. The JAK–STAT signaling pathway: input and output integration. J. Immunol. 178, 2623–2629 (2007).
  Article CAS PubMed Google Scholar
• Krausgruber, T. et al. IRF5 promotes inflammatory macrophage polarization and TH1–TH17 responses. Nature Immunol. 12, 231–238 (2011).
  Article CAS Google Scholar
• Satoh, T. et al. The Jmjd3–Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nature Immunol. 11, 936–944 (2010).
  Article CAS Google Scholar
• Moore, K. W., de Waal Malefyt, R., Coffman, R. L. & O'Garra, A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19, 683–765 (2001).
  Article CAS PubMed Google Scholar
• Hoffmann, K. F., Cheever, A. W. & Wynn, T. A. IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis. J. Immunol. 164, 6406–6416 (2000).
  Article CAS PubMed Google Scholar
• Rutschman, R. et al. Cutting edge: Stat6-dependent substrate depletion regulates nitric oxide production. J. Immunol. 166, 2173–2177 (2001).
  Article CAS PubMed Google Scholar
• Obermajer, N. et al. Induction and stability of human TH17 cells require endogenous NOS2 and cGMP-dependent NO signaling. J. Exp. Med. 210, 1433–1445 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Bronte, V., Serafini, P., Mazzoni, A., Segal, D. M. & Zanovello, P. L-arginine metabolism in myeloid cells controls T-lymphocyte functions. Trends Immunol. 24, 302–306 (2003).
  Article CAS PubMed Google Scholar
• Hesse, M., Cheever, A. W., Jankovic, D. & Wynn, T. A. NOS-2 mediates the protective anti-inflammatory and antifibrotic effects of the TH1-inducing adjuvant, IL-12, in a TH2 model of granulomatous disease. Am. J. Pathol. 157, 945–955 (2000). This study suggests a crucial role for IFNγ-primed NOS2-expressing macrophages in the suppression of type 2-mediated inflammation and fibrosis.
  Article CAS PubMed PubMed Central Google Scholar
• Xiong, Y., Karupiah, G., Hogan, S. P., Foster, P. S. & Ramsay, A. J. Inhibition of allergic airway inflammation in mice lacking nitric oxide synthase 2. J. Immunol. 162, 445–452 (1999).
  CAS PubMed Google Scholar
• El Kasmi, K. C. et al. Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nature Immunol. 9, 1399–1406 (2008).
  Article CAS Google Scholar
• Herbert, D. R. et al. Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity 20, 623–635 (2004).
  Article CAS PubMed Google Scholar
• Vannella, K. M. et al. Incomplete deletion of IL-4Rα by LysMCre reveals distinct subsets of M2 macrophages controlling inflammation and fibrosis in chronic schistosomiasis. PLoS Pathog. 10, e1004372 (2014). This study suggests that distinct populations of IL-13-primed arginase 1-expressing macrophages are responsible for the suppression of inflammation and fibrosis in chronic schistosomiasis, which is a disease associated with dominant type 2 cytokine expression.
  Article PubMed PubMed Central CAS Google Scholar
• Pesce, J. T. et al. Arginase-1-expressing macrophages suppress TH2 cytokine-driven inflammation and fibrosis. PLoS Pathog. 5, e1000371 (2009).
  Article PubMed PubMed Central CAS Google Scholar
• Albina, J. E., Mills, C. D., Henry, W. L. Jr & Caldwell, M. D. Temporal expression of different pathways of 1-arginine metabolism in healing wounds. J. Immunol. 144, 3877–3880 (1990).
  CAS PubMed Google Scholar
• Sandler, N. G., Mentink-Kane, M. M., Cheever, A. W. & Wynn, T. A. Global gene expression profiles during acute pathogen-induced pulmonary inflammation reveal divergent roles for TH1 and TH2 responses in tissue repair. J. Immunol. 171, 3655–3667 (2003).
  Article CAS PubMed Google Scholar
• Witte, M. B. & Barbul, A. Arginine physiology and its implication for wound healing. Wound Repair Regen. 11, 419–423 (2003).
  Article PubMed Google Scholar
• Thompson, R. W. et al. Cationic amino acid transporter-2 regulates immunity by modulating arginase activity. PLoS Pathog. 4, e1000023 (2008).
  Article PubMed PubMed Central CAS Google Scholar
• Barron, L. et al. Role of arginase 1 from myeloid cells in TH2-dominated lung inflammation. PLoS ONE 8, e61961 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Nieuwenhuizen, N. E. et al. Allergic airway disease is unaffected by the absence of IL-4Rα-dependent alternatively activated macrophages. J. Allergy Clin. Immunol. 130, 743–750. e8 (2012).
  Article CAS PubMed Google Scholar
• Zea, A. H. et al. Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res. 65, 3044–3048 (2005).
  Article CAS PubMed Google Scholar
• Egawa, M. et al. Inflammatory monocytes recruited to allergic skin acquire an anti-inflammatory M2 phenotype via basophil-derived interleukin-4. Immunity 38, 570–580 (2013).
  Article CAS PubMed Google Scholar
• Nair, M. G. et al. Alternatively activated macrophage-derived RELM-α is a negative regulator of type 2 inflammation in the lung. J. Exp. Med. 206, 937–952 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Pesce, J. T. et al. Retnla (relmα/fizz1) suppresses helminth-induced TH2-type immunity. PLoS Pathog. 5, e1000393 (2009).
  Article PubMed PubMed Central CAS Google Scholar
• Fiorentino, D. F. et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by TH1 cells. J. Immunol. 146, 3444–3451 (1991).
  CAS PubMed Google Scholar
• Sher, A., Fiorentino, D., Caspar, P., Pearce, E. & Mosmann, T. Production of IL-10 by CD4+ T lymphocytes correlates with down-regulation of TH1 cytokine synthesis in helminth infection. J. Immunol. 147, 2713–2716 (1991).
  CAS PubMed Google Scholar
• Wynn, T. A. et al. IL-10 regulates liver pathology in acute murine Schistosomiasis mansoni but is not required for immune down-modulation of chronic disease. J. Immunol. 160, 4473–4480 (1998).
  CAS PubMed Google Scholar
• Schopf, L. R., Hoffmann, K. F., Cheever, A. W., Urban, J. F. Jr & Wynn, T. A. IL-10 is critical for host resistance and survival during gastrointestinal helminth infection. J. Immunol. 168, 2383–2392 (2002).
  Article CAS PubMed Google Scholar
• Del Prete, G. et al. Human IL-10 is produced by both type 1 helper (TH1) and type 2 helper (TH2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol. 150, 353–360 (1993).
  CAS PubMed Google Scholar
• Grunig, G. et al. Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. J. Exp. Med. 185, 1089–1099 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Akbari, O., DeKruyff, R. H. & Umetsu, D. T. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nature Immunol. 2, 725–731 (2001).
  Article CAS Google Scholar
• Akdis, M. et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J. Exp. Med. 199, 1567–1575 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Meiler, F. et al. In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. J. Exp. Med. 205, 2887–2898 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Kearley, J., Barker, J. E., Robinson, D. S. & Lloyd, C. M. Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent. J. Exp. Med. 202, 1539–1547 (2005). This study shows that T Reg cells can suppress allergen-driven T H 2 cell responses by an IL-10-dependent mechanism but that IL-10 production by the T Reg cells themselves was not strictly required.
  Article CAS PubMed PubMed Central Google Scholar
• Awasthi, A. et al. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nature Immunol. 8, 1380–1389 (2007).
  Article CAS Google Scholar
• Stumhofer, J. S. et al. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nature Immunol. 8, 1363–1371 (2007).
  Article CAS Google Scholar
• Miyazaki, Y. et al. Exacerbation of experimental allergic asthma by augmented TH2 responses in WSX-1-deficient mice. J. Immunol. 175, 2401–2407 (2005).
  Article CAS PubMed Google Scholar
• Artis, D. et al. The IL-27 receptor (WSX-1) is an inhibitor of innate and adaptive elements of type 2 immunity. J. Immunol. 173, 5626–5634 (2004).
  Article CAS PubMed Google Scholar
• Taylor, M. D. et al. Early recruitment of natural CD4+ Foxp3+ TReg cells by infective larvae determines the outcome of filarial infection. Eur. J. Immunol. 39, 192–206 (2009).
  Article CAS PubMed Google Scholar
• Hesse, M. et al. The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. J. Immunol. 172, 3157–3166 (2004).
  Article CAS PubMed Google Scholar
• Mangan, N. E. et al. Helminth infection protects mice from anaphylaxis via IL-10-producing B cells. J. Immunol. 173, 6346–6356 (2004).
  Article CAS PubMed Google Scholar
• Wilson, M. S. et al. Helminth-induced CD19+CD23hi B cells modulate experimental allergic and autoimmune inflammation. Eur. J. Immunol. 40, 1682–1696 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Schreiber, T. H. et al. Therapeutic TReg expansion in mice by TNFRSF25 prevents allergic lung inflammation. J. Clin. Invest. 120, 3629–3640 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Barrat, F. J. et al. In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (TH1)- and TH2-inducing cytokines. J. Exp. Med. 195, 603–616 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Yazdanbakhsh, M., Kremsner, P. G. & van Ree, R. Allergy, parasites, and the hygiene hypothesis. Science 296, 490–494 (2002).
  Article CAS PubMed Google Scholar
• Fallon, P. G. & Mangan, N. E. Suppression of TH2-type allergic reactions by helminth infection. Nature Rev. Immunol. 7, 220–230 (2007). This is an excellent and comprehensive review describing how helminth infections and helminth antigens might be used in the treatment of T H 2-type allergic disorders.
  Article CAS Google Scholar
• Harnett, W. & Harnett, M. M. Helminth-derived immunomodulators: can understanding the worm produce the pill? Nature Rev. Immunol. 10, 278–284 (2010).
  Article CAS Google Scholar
• Bashir, M. E., Andersen, P., Fuss, I. J., Shi, H. N. & Nagler-Anderson, C. An enteric helminth infection protects against an allergic response to dietary antigen. J. Immunol. 169, 3284–3292 (2002).
  Article CAS PubMed Google Scholar
• Wilson, M. S. et al. Suppression of allergic airway inflammation by helminth-induced regulatory T cells. J. Exp. Med. 202, 1199–1212 (2005). This was a groundbreaking study showing that helminth-induced T Reg cells could suppress allergic airway inflammation in mice.
  Article CAS PubMed PubMed Central Google Scholar
• Schnoeller, C. et al. A helminth immunomodulator reduces allergic and inflammatory responses by induction of IL-10-producing macrophages. J. Immunol. 180, 4265–4272 (2008).
  Article CAS PubMed Google Scholar
• O'Shea, J. J. & Murray, P. J. Cytokine signaling modules in inflammatory responses. Immunity 28, 477–487 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Seki, Y. et al. SOCS-3 regulates onset and maintenance of TH2-mediated allergic responses. Nature Med. 9, 1047–1054 (2003). This study shows that SOCS3 regulates not only the initiation but also the maintenance of T H 2 cell-mediated allergic disease, which suggests that SOCS3 might represent a therapeutic target for a range of T H 2 cell-driven diseases.
  Article CAS PubMed Google Scholar
• Dickensheets, H. et al. Suppressor of cytokine signaling-1 is an IL-4-inducible gene in macrophages and feedback inhibits IL-4 signaling. Genes Immun. 8, 21–27 (2007).
  Article CAS PubMed Google Scholar
• Lee, C. et al. Suppressor of cytokine signalling 1 (SOCS1) is a physiological regulator of the asthma response. Clin. Exp. Allergy 39, 897–907 (2009). This study identifies SOCS1 is an imporant inhibitor of allergic airway inflammation.
  Article CAS PubMed PubMed Central Google Scholar
• Kim, T. H. et al. Expression of SOCS1 and SOCS3 is altered in the nasal mucosa of patients with mild and moderate/severe persistent allergic rhinitis. Int. Arch. Allergy Immunol. 158, 387–396 (2012).
  Article CAS PubMed Google Scholar
• Kinjyo, I. et al. Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor-β 1. J. Exp. Med. 203, 1021–1031 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Ozaki, A., Seki, Y., Fukushima, A. & Kubo, M. The control of allergic conjunctivitis by suppressor of cytokine signaling (SOCS)3 and SOCS5 in a murine model. J. Immunol. 175, 5489–5497 (2005).
  Article CAS PubMed Google Scholar
• Zafra, M. P. et al. Gene silencing of SOCS3 by siRNA intranasal delivery inhibits asthma phenotype in mice. PLoS ONE 9, e91996 (2014).
  Article PubMed CAS Google Scholar
• Kelly-Welch, A. E., Hanson, E. M., Boothby, M. R. & Keegan, A. D. Interleukin-4 and interleukin-13 signaling connections maps. Science 300, 1527–1528 (2003).
  Article CAS PubMed Google Scholar
• Munitz, A., Brandt, E. B., Mingler, M., Finkelman, F. D. & Rothenberg, M. E. Distinct roles for IL-13 and IL-4 via IL-13 receptor α1 and the type II IL-4 receptor in asthma pathogenesis. Proc. Natl Acad. Sci. USA 105, 7240–7245 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• LaPorte, S. L. et al. Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system. Cell 132, 259–272 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Wood, N. et al. Enhanced interleukin (IL)-13 responses in mice lacking IL-13 receptor α 2. J. Exp. Med. 197, 703–709 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Lupardus, P. J., Birnbaum, M. E. & Garcia, K. C. Molecular basis for shared cytokine recognition revealed in the structure of an unusually high affinity complex between IL-13 and IL-13Rα2. Structure 18, 332–342 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Mentink-Kane, M. M. & Wynn, T. A. Opposing roles for IL-13 and IL-13 receptor α2 in health and disease. Immunol. Rev. 202, 191–202 (2004).
  Article CAS PubMed Google Scholar
• Chiaramonte, M. G. et al. Regulation and function of the interleukin 13 receptor α2 during a T helper cell type 2-dominant immune response. J. Exp. Med. 197, 687–701 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Mentink-Kane, M. M. et al. IL-13 receptor α2 down-modulates granulomatous inflammation and prolongs host survival in schistosomiasis. Proc. Natl Acad. Sci. USA 101, 586–590 (2004).
  Article CAS PubMed Google Scholar
• Graham, B. B. et al. Schistosomiasis-induced experimental pulmonary hypertension: role of interleukin-13 signaling. Am. J. Pathol. 177, 1549–1561 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Morimoto, M. et al. Functional importance of regional differences in localized gene expression of receptors for IL-13 in murine gut. J. Immunol. 176, 491–495 (2006).
  Article CAS PubMed Google Scholar
• Morimoto, M. et al. IL-13 receptor α2 regulates the immune and functional response to Nippostrongylus brasiliensis infection. J. Immunol. 183, 1934–1939 (2009).
  Article CAS PubMed Google Scholar
• Yasunaga, S. et al. The negative-feedback regulation of the IL-13 signal by the IL-13 receptor α2 chain in bronchial epithelial cells. Cytokine 24, 293–303 (2003).
  Article CAS PubMed Google Scholar
• Zhao, Y. et al. Lysophosphatidic acid induces interleukin-13 (IL-13) receptor α2 expression and inhibits IL-13 signaling in primary human bronchial epithelial cells. J. Biol. Chem. 282, 10172–10179 (2007).
  Article CAS PubMed Google Scholar
• Andrews, A. L. et al. IL-13 receptor α2: a regulator of IL-13 and IL-4 signal transduction in primary human fibroblasts. J. Allergy Clin. Immunol. 118, 858–865 (2006).
  Article CAS PubMed Google Scholar
• Wilson, M. S. et al. IL-13Rα2 and IL-10 coordinately suppress airway inflammation, airway-hyperreactivity, and fibrosis in mice. J. Clin. Invest. 117, 2941–2951 (2007). This study shows that IL-13Rα2 and IL-10 are both required for the suppression of airway inflammation, airway hyperresponsiveness and fibrosis in models of allergic asthma.
  Article CAS PubMed PubMed Central Google Scholar
• Zheng, T. et al. IL-13 receptor α2 selectively inhibits IL-13-induced responses in the murine lung. J. Immunol. 180, 522–529 (2008).
  Article CAS PubMed Google Scholar
• van Scott, M. R. et al. IL-10 reduces TH2 cytokine production and eosinophilia but augments airway reactivity in allergic mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 278, L667–L674 (2000).
  Article CAS PubMed Google Scholar
• Hadeiba, H. & Locksley, R. M. Lung CD25 CD4 regulatory T cells suppress type 2 immune responses but not bronchial hyperreactivity. J. Immunol. 170, 5502–5510 (2003).
  Article CAS PubMed Google Scholar
• Makela, M. J. et al. IL-10 is necessary for the expression of airway hyperresponsiveness but not pulmonary inflammation after allergic sensitization. Proc. Natl Acad. Sci. USA 97, 6007–6012 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Wilson, M. S. et al. Colitis and intestinal inflammation in _IL10_−/− mice results from IL-13Rα2-mediated attenuation of IL-13 activity. Gastroenterology 140, 254–264 (2011).
  Article CAS PubMed Google Scholar
• Herbert, D. R. et al. Intestinal epithelial cell secretion of RELM-β protects against gastrointestinal worm infection. J. Exp. Med. 206, 2947–2957 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Mentink-Kane, M. M. et al. Accelerated and progressive and lethal liver fibrosis in mice that lack interleukin (IL)-10, IL-12p40, and IL-13Rα2. Gastroenterology 141, 2200–2209 (2011). This study shows that the progression of IL-13-dependent liver cirrhosis is slowed substantially by the combined inhibitory actions of IL-10, IL-12 and IL-13Rα2.
  Article CAS PubMed Google Scholar
• Fallon, P. G., Richardson, E. J., McKenzie, G. J. & McKenzie, A. N. Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent. J. Immunol. 164, 2585–2591 (2000).
  Article CAS PubMed Google Scholar
• Ramalingam, T. R. et al. Unique functions of the type II interleukin 4 receptor identified in mice lacking the interleukin 13 receptor α1 chain. Nature Immunol. 9, 25–33 (2008).
  Article CAS Google Scholar
• Agrawal, S. & Townley, R. G. Role of periostin, FENO, IL-13, lebrikzumab, other IL-13 antagonist and dual IL-4/IL-13 antagonist in asthma. Expert Opin. Biol. Ther. 14, 165–181 (2014).
  Article CAS PubMed Google Scholar
• Zagury, D., Burny, A. & Gallo, R. C. Toward a new generation of vaccines: the anti-cytokine therapeutic vaccines. Proc. Natl Acad. Sci. USA 98, 8024–8029 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Richard, M., Grencis, R. K., Humphreys, N. E., Renauld, J. C. & Van Snick, J. Anti-IL-9 vaccination prevents worm expulsion and blood eosinophilia in _Trichuris muris_-infected mice. Proc. Natl Acad. Sci. USA 97, 767–772 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Oh, C. K., Geba, G. P. & Molfino, N. Investigational therapeutics targeting the IL-4/IL-13/STAT-6 pathway for the treatment of asthma. Eur. Respir. Rev. 19, 46–54 (2010).
  Article CAS PubMed Google Scholar
• Wenzel, S. et al. Dupilumab in persistent asthma with elevated eosinophil levels. N. Engl. J. Med. 368, 2455–2466 (2013).
  Article CAS PubMed Google Scholar
• Corren, J. et al. Lebrikizumab treatment in adults with asthma. N. Engl. J. Med. 365, 1088–1098 (2011).
  Article CAS PubMed Google Scholar
• Rosenberg, H. F., Dyer, K. D. & Foster, P. S. Eosinophils: changing perspectives in health and disease. Nature Rev. Immunol. 13, 9–22 (2013). This is a comprehensive review examining the development, recruitment and activation of eosinophils in homeostasis and in a range of disease states.
  Article CAS Google Scholar
• Licona-Limon, P., Kim, L. K., Palm, N. W. & Flavell, R. A. TH2, allergy and group 2 innate lymphoid cells. Nature Immunol. 14, 536–542 (2013). This is an excellent review examining the regulatory roles of TSLP, IL-25, IL-33 and ILC2s in the type 2 response to helminths and allergens and in the maintenance of homeostasis.
  Article CAS Google Scholar
• Wenzel, S. E. Eosinophils in asthma — closing the loop or opening the door? N. Engl. J. Med. 360, 1026–1028 (2009).
  Article CAS PubMed Google Scholar
• Reiman, R. M. et al. Interleukin-5 (IL-5) augments the progression of liver fibrosis by regulating IL-13 activity. Infect. Immun. 74, 1471–1479 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Swartz, J. M. et al. Schistosoma mansoni infection in eosinophil lineage-ablated mice. Blood 108, 2420–2427 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Fort, M. M. et al. IL-25 induces IL-4, IL-5, and IL-13 and TH2-associated pathologies in vivo. Immunity 15, 985–995 (2001).
  Article CAS PubMed Google Scholar
• Soumelis, V. et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nature Immunol. 3, 673–680 (2002).
  Article CAS Google Scholar
• Schmitz, J. et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23, 479–490 (2005).
  Article CAS PubMed Google Scholar
• Comeau, M. R. & Ziegler, S. F. The influence of TSLP on the allergic response. Mucosal Immunol. 3, 138–147 (2010).
  Article CAS PubMed Google Scholar
• Willart, M. A. et al. Interleukin-1α controls allergic sensitization to inhaled house dust mite via the epithelial release of GM–CSF and IL-33. J. Exp. Med. 209, 1505–1517 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Jang, S., Morris, S. & Lukacs, N. W. TSLP promotes induction of TH2 differentiation but is not necessary during established allergen-induced pulmonary disease. PLoS ONE 8, e56433 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Ramalingam, T. R. et al. Regulation of helminth-induced TH2 responses by thymic stromal lymphopoietin. J. Immunol. 182, 6452–6459 (2009).
  Article CAS PubMed Google Scholar
• Oboki, K. et al. IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc. Natl Acad. Sci. USA 107, 18581–18586 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Massacand, J. C. et al. Helminth products bypass the need for TSLP in TH2 immune responses by directly modulating dendritic cell function. Proc. Natl Acad. Sci. USA 106, 13968–13973 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Gauvreau, G. M. et al. Effects of an anti-TSLP antibody on allergen-induced asthmatic responses. N. Engl. J. Med. 370, 2102–2110 (2014). This is an exciting clinical study showing that antibodies specific for TSLP reduced allergen-induced airway responses and inflammation in patients with allergy who were challenged with allergen.
  Article PubMed CAS Google Scholar
• Islam, S. A. & Luster, A. D. T cell homing to epithelial barriers in allergic disease. Nature Med. 18, 705–715 (2012).
  Article CAS PubMed Google Scholar
• Larche, M., Akdis, C. A. & Valenta, R. Immunological mechanisms of allergen-specific immunotherapy. Nature Rev. Immunol. 6, 761–771 (2006).
  Article CAS Google Scholar
• Busse, W. W. et al. Daclizumab improves asthma control in patients with moderate to severe persistent asthma: a randomized, controlled trial. Am. J. Respir. Crit. Care Med. 178, 1002–1008 (2008).
  Article CAS PubMed Google Scholar
• Claar, D., Hartert, T. V. & Peebles, R. S. Jr. The role of prostaglandins in allergic lung inflammation and asthma. Expert Rev. Respir. Med. 9, 55–72 (2015).
  Article CAS PubMed Google Scholar
• Wammes, L. J., Mpairwe, H., Elliott, A. M. & Yazdanbakhsh, M. Helminth therapy or elimination: epidemiological, immunological, and clinical considerations. Lancet Infect. Dis. 14, 1150–1162 (2014).
  Article CAS PubMed Google Scholar
• Fahy, J. V. Type 2 inflammation in asthma — present in most, absent in many. Nature Rev. Immunol. 15, 57–65 (2015).
  Article CAS Google Scholar
• Qiu, Y. et al. Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat. Cell 157, 1292–1308 (2014).
  Article CAS PubMed PubMed Central Google Scholar